about
Liquid biopsy in early stage lung cancerMET: a new promising biomarker in non-small-cell lung carcinoma.Molecular biomarkers in colorectal carcinoma.De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer.Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer.MET/HGF targeted drugs as potential therapeutic strategies in non-small cell lung cancer.PTEN and PI3K/AKT in non-small-cell lung cancer.Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer.Gene polymorphisms as predictors of response to biological therapies in psoriasis patients.Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?Apoptosis and necrosis in human ejaculated spermatozoa.Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer.ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis.Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.Extrapolation of acenocoumarol pharmacogenetic algorithms.Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm.Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.Pharmacogenetics role in the safety of acenocoumarol therapy.ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.Novel BRAFI599InsMutation Identified in a Follicular Variant of a Papillary Thyroid Carcinoma: A Molecular Modeling ApproachGenomic approaches in the search for molecular biomarkers in chronic kidney diseasePharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patientsEffect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 IndividualsInformation on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk FactorsImpact of single nucleotide polymorphisms on the efficacy and toxicity of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients
P50
Q28065994-FB71016E-9CD2-4430-92F9-7A251D8AEF2AQ38430194-7D44253E-9C4D-48DF-B8BB-B8518EC7FB2BQ38559669-24766E02-950E-416B-BA08-C7D6E96752ADQ38563592-D5DA5FAF-7EDC-468B-B233-7C89F98FDE13Q38591976-B0E508C5-AFF7-46DB-A90E-096018916191Q38594380-DD92D3FE-FA83-407D-9C96-F3B5D4ABD086Q38629644-068E9E03-D833-4ED5-9FC6-A225EC655130Q38876830-77AF71BC-8DD7-462E-A708-05600942045EQ38927667-B6AB88B2-1B17-4C58-9F1B-506180308C55Q44216626-BC6FA2E8-C752-4E5C-A55A-A11BC0E66653Q44785386-68A241E6-B4B1-47C2-9583-89651AE887B5Q45394571-6680491B-1B16-4EDD-AABC-89E975E0F8E5Q49996843-B7E2A9BA-A23B-45AC-B20C-26A7B51500BCQ50118244-89EA2553-6A6B-4F2B-BD78-D50DE9908456Q50503667-307B8864-8A06-4D58-9F80-95BA8BED7CCFQ50582912-CDCFEB22-259C-4838-898E-823BF22EDCBEQ50891059-59E5008D-8F6B-46DD-B7A5-BFA1455C0661Q51061872-8CBDBA18-3962-4A34-A42B-D16BE99D133BQ51684306-0450E8B7-E8E2-487F-B920-F0466FCCE362Q53088616-D5C9EC11-B38D-468E-86E7-B30B9EEC9788Q53109049-23CCC88A-2C2A-4DAB-9BF2-6421F843708FQ57340309-D18697D0-249A-42B8-933D-E1D24FDA2809Q57788041-3D901615-E510-4BE7-BFE4-5725F6E41C90Q88377288-9BE06A4F-1BB2-4F2C-B3B0-B3DD05A9C52BQ90162386-C245F8E7-1FE7-4243-BDF5-7428FC6286BDQ91651559-641CB3B6-8B03-4DB1-B36D-7E97993CE848Q92644513-26BC276B-2779-4AC3-826A-EE4EF4FD92BC
P50
description
researcher
@en
name
Maria Luisa Cañadas
@en
Maria Luisa Cañadas
@nl
type
label
Maria Luisa Cañadas
@en
Maria Luisa Cañadas
@nl
prefLabel
Maria Luisa Cañadas
@en
Maria Luisa Cañadas
@nl
P106
P31
P496
0000-0003-1103-5658